Shawn Cross
Chief Financial Officer · 3 filings · Latest: Apr 23, 2026
Pacira BioSciences, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PCRX | Shawn Cross | Chief Financial Officer | Apr 23, 2026 | Sale | $25.16 | 12,941 | $325.6K | 105,341 | |
PCRX | Shawn Cross | Chief Financial Officer | Apr 23, 2026 | Option Exercise | $16.45 | 12,941 | $212.9K | 118,282 | |
PCRX | Cross Shawn | — | Apr 23, 2026 | Proposed Sale | $25.16 | 12,941 | $325.6K | — | |
PCRX | Shawn Cross | Chief Financial Officer | Apr 22, 2026 | Sale | $25.01 | 1,500 | $37.5K | 105,341 | |
PCRX | Shawn Cross | Chief Financial Officer | Apr 22, 2026 | Option Exercise | $16.45 | 1,500 | $24.7K | 106,841 | |
PCRX | Shawn Cross | Chief Financial Officer | Apr 21, 2026 | Sale | $25.01 | 2,845 | $71.2K | 105,341 | |
PCRX | Shawn Cross | Chief Financial Officer | Apr 21, 2026 | Option Exercise | $16.45 | 2,845 | $46.8K | 108,186 | |
PCRX | Shawn Cross | Chief Financial Officer | Apr 20, 2026 | Sale | $25.14 | 7,714 | $193.9K | 105,341 | |
PCRX | Shawn Cross | Chief Financial Officer | Apr 20, 2026 | Option Exercise | $16.45 | 7,714 | $126.9K | 113,055 | |
PCRX | Cross Shawn | — | Apr 22, 2026 | Proposed Sale | $25.01 | 1,500 | $37.5K | — | |
PCRX | Cross Shawn | — | Apr 21, 2026 | Proposed Sale | $25.01 | 2,845 | $71.1K | — | |
PCRX | Cross Shawn | — | Apr 20, 2026 | Proposed Sale | $25.14 | 7,714 | $193.9K | — | |
PCRX | Cross Shawn | — | Dec 10, 2025 | Proposed Sale | $25.14 | 9,104 | $228.9K | — | |
PCRX | Cross Shawn | — | Dec 9, 2025 | Proposed Sale | $25.03 | 15,896 | $397.8K | — | |
PCRX | Cross Shawn | — | Nov 10, 2025 | Proposed Sale | $22.09 | 12,060 | $266.4K | — |